CML Support Group

Chronic Myeloid Leukaemia online support group, active since 2000.

[International CML Foundation @icmlf]

Join our iCMLf Conversation ‘CML EHA Highlights’ & hear Professor Andreas Hochhaus share insights from his presentation Late line treatment in chronic phase & key clinical CML highlights from the congress. Join us July 12 & hear from a renowned CML expert: https://t.co/xZzeyB0VLG

[International CML Foundation @icmlf]

"Should patients switch TKIs periodically to reduce toxicity impact?” Watch as CML experts Professors Tim Hughes & Jeff Lipton answered this and other #CML management questions during our latest iCMLf Conversation: https://t.co/vRX4JvFXGq

[CML Support Group @CMLSupportGroup]

we just joined the Huberman Lab Neural Network Newsletter https://t.co/tkOm0hsd18 via @hubermanlab

[Dr. Joseph Mercola @mercola]

Is Aspirin the target of a discrediting campaign?

For decades, a daily regimen of low-dose so-called “baby aspirin” (81milligrams), was recommended to prevent and treat heart attack, stroke and angina (chest pain) in those 50 and older.

That began to change in 2014, when the U.S. Food and Drug Administration started warning against the use of aspirin as a primary preventive for these conditions. In late 2021, the United States Preventive Services Task Force (USPSTF) also updated its guidance to formally discourage people 60 and older from using an aspirin regimen to prevent a first heart attack or stroke.

Aspirin is likely the victim of an intentional pharma discrediting campaign to justify and promote the use of newer, patented and far more expensive nonsteroidal anti-inflammatory drugs (NSAIDs) and anticoagulants.

Research has shown aspirin works just as well as pricier anticoagulants such as heparin and Xarelto for preventing post-operative blood clots and clots associated with bone fractures (See image below).

Aspirin also increases the oxidation of glucose as fuel, and has anti-lipolytic effects, so it helps lower both the supply of dangerous omega-6 fat to your cells and the excessive oxidation of fats. Aspirin will also lower your baseline cortisol, indirectly by lowering inflammation, and directly by inhibiting the enzyme that synthesizes active cortisol from the inactive precursor cortisone.

Learn more at Mercola DOT com about pharma’s intentional attack on Aspirin.

[International CML Foundation @icmlf]

Today we show our support to all cancer patients as part of World Cancer Day. A day dedicated to raising awareness & working together to create a world where preventable cancer deaths are stopped & life-saving cancer treatment & care is accessible for all global citizens.

[ALASTAIR CAMPBELL @campbellclaret]

Superb interview by @JujuliaGrace …

[CML Support Group @CMLSupportGroup]

Why is strep A surging — and how worried are scientists? https://t.co/qMD5jU8RTf

[CML Support Group @CMLSupportGroup]

New Boston virus https://t.co/DCfCYiXtvg via @YouTube

[International CML Foundation @icmlf]

Did you miss our latest iCMLf Conversation: 'Meet the #CML Expert' with Professors Jane Apperley and Giuseppe Saglio? It's now available to view online! Watch and listen as they discuss important topics and answer relevant questions relating to CML https://t.co/gP3jEpfGHZ

[International CML Foundation @icmlf]

Join us October 26 2PM CEST for our next iCMLf Conversation from the 24th John Goldman Conference. Listen as Professors Jorge Cortes & Daniela Krauseus provide an overview of the clinical & biological aspects presented at the conference. More information: https://t.co/QJr8Fk4KzP

[International CML Foundation @icmlf]

We’re pleased to share the #CML ‘papers of the month’ as selected by Professor Timothy Hughes. Professor Hughes’ selection of relevant CML papers published in September can be found on our website here: https://t.co/XrEBbPynZZ

[International CML Foundation @icmlf]

Submit your questions in advance to the upcoming 'Meet the CML Experts' iCMLf Conversation on 21/9/22 at 2pm CEST. Ask your CML-related questions to Professors Jane Apperley & Giuseppe Saglio to get their opinions and expertise. Find out more here: https://t.co/kgBDPKQrPT

[CML Support Group @CMLSupportGroup]

https://t.co/ypikVEQnBK

[International CML Foundation @icmlf]

Had a patient present with Ophthalmologic manifestations upon #CML diagnosis? We recommend viewing our latest Presentation in Module 5 of the iCMLf Knowledge Centre ‘Managing Comorbidities - Ophthalmologic manifestations’ to better understand this, here https://t.co/YRUhq283NC

[International CML Foundation @icmlf]

Have questions only #CML experts can answer? Join our ‘Meet the CML Expert’ iCMLf virtual Conversation September 21! Professors Jane Apperley & Giuseppe Saglio will provide insights into CML cases, research & management at 2pm CEST. More info https://t.co/6W0SrqkHXT

[CML Support Group @CMLSupportGroup]

Thai vaccine study https://t.co/VCFaOWy2bj via @YouTube

[Strawfie Challenge @strawfie]

@ChristopherPBS @evusheld4theuk @bloodcancer_uk @Kidney_Research @kidneycareuk Sign/RT evusheld petition too:
https://t.co/BcbQHcnMXr

[Mark Oakley @MarkOak04974342]

@ChristopherPBS @evusheld4theuk @bloodcancer_uk @Kidney_Research @kidneycareuk Thank you so much for your support. @evusheld4theuk we really appreciate this on behalf of those we represent. A solution for us to live our luves and a solution to ease the pressure on the NHS to free beds and resources for over patienrs this winter

[Rob Relyea @rrelyea]

Good data on Evusheld protection from a study from israel. Protective to avoid infection. Very protective to avoid hospitalization

[International CML Foundation @icmlf]

We’re pleased to share the #CML ‘papers of the month’ as selected by Professor Timothy Hughes. Professor Hughes’ selection of relevant CML papers published in June can be found on our website https://t.co/uXniLg3IX6